Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 222

1.

Bacterial flora as a cause or treatment of chronic diarrhea.

Scaldaferri F, Pizzoferrato M, Pecere S, Forte F, Gasbarrini A.

Gastroenterol Clin North Am. 2012 Sep;41(3):581-602. doi: 10.1016/j.gtc.2012.06.002. Epub 2012 Jul 23. Review.

PMID:
22917165
2.

Prebiotics, probiotics and digestive health.

Balakrishnan M, Floch MH.

Curr Opin Clin Nutr Metab Care. 2012 Nov;15(6):580-5. doi: 10.1097/MCO.0b013e328359684f. Review.

PMID:
23037903
3.

Intestinal microbiota in functional bowel disorders: a Rome foundation report.

Simrén M, Barbara G, Flint HJ, Spiegel BM, Spiller RC, Vanner S, Verdu EF, Whorwell PJ, Zoetendal EG; Rome Foundation Committee.

Gut. 2013 Jan;62(1):159-76. doi: 10.1136/gutjnl-2012-302167. Epub 2012 Jun 22.

4.

Gut microbial flora, prebiotics, and probiotics in IBD: their current usage and utility.

Scaldaferri F, Gerardi V, Lopetuso LR, Del Zompo F, Mangiola F, Boškoski I, Bruno G, Petito V, Laterza L, Cammarota G, Gaetani E, Sgambato A, Gasbarrini A.

Biomed Res Int. 2013;2013:435268. doi: 10.1155/2013/435268. Epub 2013 Aug 7. Review.

5.

The bacterial flora in inflammatory bowel disease: current insights in pathogenesis and the influence of antibiotics and probiotics.

Linskens RK, Huijsdens XW, Savelkoul PH, Vandenbroucke-Grauls CM, Meuwissen SG.

Scand J Gastroenterol Suppl. 2001;(234):29-40. Review.

PMID:
11768558
6.

Review article: gut flora and inflammatory bowel disease.

Marteau P, Lepage P, Mangin I, Suau A, Doré J, Pochart P, Seksik P.

Aliment Pharmacol Ther. 2004 Oct;20 Suppl 4:18-23. Review.

7.

Bacteria in the pathogenesis of inflammatory bowel disease.

Subramanian S, Campbell BJ, Rhodes JM.

Curr Opin Infect Dis. 2006 Oct;19(5):475-84. Review.

PMID:
16940872
8.

Therapeutic approaches targeting intestinal microflora in inflammatory bowel disease.

Andoh A, Fujiyama Y.

World J Gastroenterol. 2006 Jul 28;12(28):4452-60. Review.

9.

Probiotics and prebiotics in chronic inflammatory bowel diseases.

Ewaschuk JB, Dieleman LA.

World J Gastroenterol. 2006 Oct 7;12(37):5941-50. Review.

10.

Role of bacteria in experimental colitis.

Guarner F, Malagelada JR.

Best Pract Res Clin Gastroenterol. 2003 Oct;17(5):793-804. Review.

PMID:
14507589
11.

Gut microbiota and inflammatory bowel disease.

Hammer HF.

Dig Dis. 2011;29(6):550-3. doi: 10.1159/000332981. Epub 2011 Dec 12. Review.

PMID:
22179210
12.

Probiotics and prebiotics in inflammatory bowel disease: microflora 'on the scope'.

Damaskos D, Kolios G.

Br J Clin Pharmacol. 2008 Apr;65(4):453-67. doi: 10.1111/j.1365-2125.2008.03096.x. Epub 2008 Feb 12. Review. Erratum in: Br J Clin Pharmacol. 2008 Aug;66(2):339.

13.

Treatment of irritable bowel syndrome with probiotics. An etiopathogenic approach at last?

Bixquert Jiménez M.

Rev Esp Enferm Dig. 2009 Aug;101(8):553-64. Review.

14.

Clinical evidence for immunomodulatory effects of probiotic bacteria.

Ruemmele FM, Bier D, Marteau P, Rechkemmer G, Bourdet-Sicard R, Walker WA, Goulet O.

J Pediatr Gastroenterol Nutr. 2009 Feb;48(2):126-41. doi: 10.1097/MPG.0b013e31817d80ca. Review.

PMID:
19179874
15.

The pathogenic role of intestinal flora in IBD and colon cancer.

Rescigno M.

Curr Drug Targets. 2008 May;9(5):395-403. Review.

PMID:
18473768
16.

The intestinal microbiota and chronic disorders of the gut.

DuPont AW, DuPont HL.

Nat Rev Gastroenterol Hepatol. 2011 Aug 16;8(9):523-31. doi: 10.1038/nrgastro.2011.133. Review.

PMID:
21844910
17.

Bacterial overgrowth as a cause of irritable bowel syndrome.

Riordan SM, Kim R.

Curr Opin Gastroenterol. 2006 Nov;22(6):669-73. Review.

PMID:
17053447
18.

Intestinal microbiota in pathophysiology and management of irritable bowel syndrome.

Lee KN, Lee OY.

World J Gastroenterol. 2014 Jul 21;20(27):8886-97. doi: 10.3748/wjg.v20.i27.8886. Review.

19.

Gut microbiota and probiotics in chronic liver diseases.

Cesaro C, Tiso A, Del Prete A, Cariello R, Tuccillo C, Cotticelli G, Del Vecchio Blanco C, Loguercio C.

Dig Liver Dis. 2011 Jun;43(6):431-8. doi: 10.1016/j.dld.2010.10.015. Epub 2010 Dec 16. Review.

PMID:
21163715
20.

Potential benefits of pro- and prebiotics on intestinal mucosal immunity and intestinal barrier in short bowel syndrome.

Stoidis CN, Misiakos EP, Patapis P, Fotiadis CI, Spyropoulos BG.

Nutr Res Rev. 2011 Jun;24(1):21-30. doi: 10.1017/S0954422410000260. Epub 2010 Oct 21. Review.

PMID:
20961485
Items per page

Supplemental Content

Write to the Help Desk